BUSINESS

Looking for help with today’s New York Times Pips? We’ll walk you through today’s puzzle and help you match dominoes to tiles.

TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission.Why we love this dealWhether you’re chilling outside with friends and family or trying to park your car, it’s always nice to have some extra lighting outside when things get dark. And it’s even better if you can find a light to “set and forget.” That’s where flood lights come in. They’re a great outdoor lighting solution for your garage, yard, or patio.The $66 Szrsth Outdoor Solar Light is on sale for only $20 at Walmart right now. It’s motion-activated, solar and battery-powered, and can be controlled remotely. Need more than one light? You can also buy two lights for $30, three lights for $50, or four lights for $60.Szrsth Outdoor Solar Light, From $20 (was $66) at Walmart

Courtesy of Walmart

Shop at WalmartDetails to knowEach light is equipped with 210 LED beads, capable of producing up to 2,500 lumens. So in other words, it’s bright. It’s also solar-powered and battery-powered. When sunlight hits the small solar panel on top of the light, it generates electricity that’s sent to the battery for storage. The battery can keep the light on for up to four hours, according to the manufacturer. When the light turns on, it uses the stored electricity from the battery to keep things powered on. There’s no hardwiring or fiddling with electrical wires necessary!This light is also motion-activated; the motion sensor will detect movement from up to 26 feet away, which is actually farther than you might think. The light will turn on when movement is detected and turn off on its own when the activity clears out. You can also set the light to dim when movement is no longer detected, or have it just stay on entirely. All these settings can be controlled via the wireless remote included with your purchase.Related: Walmart has a 6-pack of waterproof solar flights on sale for $36Why do shoppers love it?Several shoppers were surprised by the brightness of the light. “I’m really impressed with these solar lights! They’re super bright and have a great motion sensor feature,” one reviewer said. “The installation was a breeze, and they look sleek on my patio. The solar panel works well, and I’ve noticed a significant reduction in my energy bill.”Others have fallen in love with the timer feature. “These lights were more than what I was expecting. The timers on the lights were set to turn on bright as long as there is motion detected and turn off seconds after the movement,” another shopper said. “They don’t turn on during daylight at all, thus saving the juice for evenings. They are a great addition to my home.”If you’re in need of a bright, reliable flood light for your home (and you want to save big), now’s your chance to get the Szrsth Outdoor Solar Light for only $20 at Walmart. There’s no telling how long this deal will stick around, though, so act fast.

Yet another major character death takes place in Season 3, Episode 6 of ‘House of the Dragon.’

Music acts came out in full force at this year’s Comic-Con, including legendary bands, an iconic rapper, a rising superstar girl group, a global K-pop group, and more.

POSCO International and LG CNS is tapping Injective network to tokenize live commercial invoices, another sign blockchain rails are moving deeper into corporate finance.

In 2014, Elon Musk stood in front of an audience and said building AI was like “summoning the demon.” In 2018 at SXSW, he said AI was “far more dangerous than nukes.”In March 2025, he put the odds of killer robots annihilating humanity at somewhere between 10% and 20%. Those are the quotes people remember. They paint a picture of a man who has spent years warning the world about what could go wrong.Then in July 2026, sitting across from The Economist’s editor-in-chief Zanny Minton Beddoes in what was his first extended interview since SpaceX’s blockbuster IPO, Musk said something that complicates that picture considerably. He said he’s made peace with pressing ahead anyway. And he explained why.What Elon Musk told The Economist about AI risks and abundance”My sort of philosophical conclusion is to look on the bright side,” Musk told The Economist.”I can’t see any way to really stop this incredible momentum of AI and robots,” he said. “At times I sort of think, well, perhaps even if there was a stop button, we probably shouldn’t press it, because the most likely outcome is incredible abundance for all.”He also said humans will “no longer be in charge of the world in 10 years.” He said it matter-of-factly, not as a warning, but as a prediction he’s made peace with.He’s not saying the risk is gone. He was explicit that the probability of things going catastrophically wrong is “not zero.” But his argument is that the upside, a world where AI creates abundance for everyone, is the more likely outcome. And he’s decided that’s enough to keep going.He also put a timeline on what he sees coming. AI may exceed the sum of all human intelligence “in about five years,” he said, leading to what he called “an age of amazing abundance where anyone can have anything they can think of.” The only scenario he sees derailing that is something like “global thermonuclear war.”Related: Mark Zuckerberg backs Elon Musk Silicon Valley decisionThe interview also had a sharper moment. When Beddoes told him “people loathe you,” Musk didn’t flinch. “I don’t care,” he said. “The fact that a quarter billion people follow me means a lot more people like me than don’t. And I think a lot more people hate you and the media than you realize.” It was the kind of exchange that reminded viewers why Musk doesn’t sit for many interviews.Why Musk’s position on AI has shifted from warning to acceptanceThe shift is worth sitting with. Musk has been one of the most prominent voices warning about AI risk for more than a decade. He co-founded OpenAI in 2015 specifically because he believed that if powerful AI was coming, it was better to have safety-conscious people at the frontier than to leave it entirely to those who weren’t thinking about the risks. He left OpenAI’s board in 2018 citing disagreements over direction.Since then he’s built xAI, launched Grok, and poured money into AI compute infrastructure. He’s watched the technology accelerate past forecasts he thought were aggressive. His 10-20% annihilation estimate from March 2025 is still there. He didn’t walk it back. What shifted is what he does with that number. If the bad outcome is 10-20% likely, then the good outcome is 80-90% likely. And he’s decided that’s enough to keep going full speed.That’s not a retraction of his earlier warnings. It’s more of a reckoning with the fact that the train has left the station, and his conclusion is that passengers are better off on it than standing on the platform hoping it stops.Musk’s AI abundance prediction and what it means in practiceMusk has been making versions of the abundance argument more explicitly in 2026. In January, he said saving for retirement would be “irrelevant” in a world of abundant AI and robotics. Earlier this month, he predicted that AI and robots would make work optional and fund what he called “universal high income,” a concept he’s described as a world where scarcity is no longer the default condition of human life, as TheStreet reported.The Economist interview is the most fully developed version of this argument he’s made publicly. He’s describing a world where the question isn’t whether AI creates enormous wealth but whether that wealth gets distributed broadly enough to justify the risk of getting there. His answer, based on the interview, is that he believes it will, and that betting against the technology at this point is both futile and probably the wrong call.That’s a significant thing to say when you’re the person who once compared AI development to summoning a demon. It reflects either a genuine philosophical evolution or a calculated public pivot. Probably some of both.

Musk has been making versions of the abundance argument more explicitly in 2026Stefani/Getty Images

What the AI risk debate looks like with Musk on the optimist sideThe AI safety community has spent years trying to get the world’s most powerful technologists to take existential risk seriously. Musk was one of the few people with genuine influence who seemed to agree. Now he’s saying the risk is real but the abundance case is stronger, and he’s not pressing stop.That matters for how the public debate about AI governance develops. If the person who put “killer robots annihilating humanity” at 10-20% odds is now making the case for accelerating anyway, it takes one of the most credible warning voices out of the cautionary camp and puts it, at least partly, in the acceleration camp.Geoffrey Hinton, the Nobel Prize-winning computer scientist who left Google specifically to warn about AI risk, has put his own probability of AI-driven human extinction at 10% over the next 30 years. That number is still out there. The debate hasn’t gone away. Musk is just no longer where he used to be in it, and that changes the shape of the conversation in ways that will take a while to fully work out.What investors and markets should take from Musk’s Economist interviewFor markets, Musk’s comments are another data point in a pattern that’s been building all year. The people closest to the technology and most invested in it, literally and financially, are increasingly making the abundance case rather than the caution case. That shapes the capital allocation decisions of the investors and institutions that listen to them.Musk himself has more money riding on the AI outcome than almost anyone. xAI, Tesla, SpaceX, and his various infrastructure investments are all deeply tied to the assumption that AI development continues and that the resulting productivity gains are real. His optimism isn’t abstract. It’s what the business model requires, as TheStreet reported.Whether that makes his optimism more credible or less credible is a question investors are going to have to answer for themselves. But his position on the debate has shifted, and the market tends to notice when someone with his platform changes what they’re saying.Related: Elon Musk’s startling claim to SpaceX investors

The Young Bucks beat Jon Moxley and Will Ospreay, whose issues reared their ugly head and cost them the match.

Personal finance author and radio host Dave Ramsey recently warned a reader who questioned whether to transition from part-time work to full-time employment, solely to accelerate her family’s long-term retirement savings. This likely would have included increasing their 401(k) and IRA contributions.The reader explained that her husband earns more than $180,000 annually in a stable role, while she currently works part-time as a substitute teacher.She noted that their existing retirement investments already position them for a comfortable lifestyle in retirement, yet her husband suggested taking on a full-time job to expand their financial reserves.Ramsey challenged the underlying assumption that higher bank account balances automatically justify sacrificing personal fulfillment.”Contentment has nothing to do with how many hours you work, or how many zeroes are in your bank account,” Ramsey wrote in an email to TheStreet from Ramsey Solutions.He emphasized that one’s financial trajectory should reflect personal well-being rather than endless accumulation.”The idea that contentment is on the same spectrum as ambition? I disagree with that notion wholeheartedly,” Ramsey added.Dave Ramsey cautions against 401(k), IRA errorFederal Reserve data indicates that middle-to-high-income households frequently struggle to identify their true income baseline needed for post-work security, often overestimating required accumulation targets.Maintaining a 401(k) and IRA retirement savings rate of 15% of annual gross income — including employer matching contributions — typically provides sufficient capital replacement over a 30-year working career, according to Fidelity Investments.I calculated that, when household income exceeds $210,000 with combined part-time earnings, achieving that benchmark generates over $31,500 in annual 401(k) and IRA retirement savings without requiring a transition to full-time work.More on personal finance:Charles Schwab, Fidelity alert workers to forced 401(k) ruleDave Ramsey warns Americans on 401(k)s, IRAs (he’s not wrong)Congress research arm warns Americans on 401(k), IRA penaltyRamsey warned against compromising current daily happiness solely to raise an already secure 401(k) and IRA balance..”But if you have to surrender the joy in life to do it, all in the name of simply increasing your amount of wealth to an even higher level, I don’t like that idea,” he wrote.Job satisfaction among educators and public service workers delivers non-financial well-being metrics that significantly reduce overall household stress levels, according to Pew Research Center studies.

Dave Ramsey urges people to consider happiness over wealth amounts alone when evaluating retirement savings and career satisfaction.Shutterstock

401(k), IRA retirement savings scenariosI calculated the following wealth accumulation models to provide real-world financial context for readers evaluating part-time versus full-time household employment and 401(k) and IRA retirement savings.The models assume a couple, much like Ramsey’s example above, with a baseline combined income of $210,000 ($180,000 primary earner plus $30,000 part-time educator income), a standardized 7% annual investment return, an estimated 22% effective federal tax rate, and a 10-year holding period.Part-time baseline scenario ($210,000 total household income)Under the part-time baseline scenario with a total household income of $210,000, allocating 15% results in an annual 401(k) and IRA retirement savings total of $31,500. Over a 10-year period, cumulative contributions reach $315,000, while projected investment growth at 7% adds $120,218. This yields a final accumulated balance of $435,218 after 10 years.Full-time transition scenario ($240,000 total household income)Transitioning to full-time employment would theoretically generate an additional $30,000 in annual income, raising total household earnings to $240,000. Maintaining a 15% allocation increases annual 401(k) and IRA retirement savings to $36,000, bringing total contributions over 10 years to $360,000. With $137,392 in projected investment growth at 7%, the final accumulated balance reaches $497,392.Opportunity cost analysisComparing the two models reveals a net asset variance of $62,174 after 10 years. Under a standard 4% retirement withdrawal rule, this difference translates to a marginal monthly drawdown gain of $207 in retirement income. Generating this incremental capital requires working an additional 10,400 labor hours over the 10-year timeframe. (Source:Jeffrey Quiggle, TheStreet.)Retirement savings impact on lifestyle choicesThe financial data suggests that transitioning from part-time to full-time labor yields a modest increase in total capital relative to the thousands of hours committed.Debt-free households earning comfortable primary salaries achieve minimal risk reduction from secondary full-time wages.Prioritizing daily career satisfaction over marginal asset gains can offer greater overall utility once core 401(k) and IRA retirement savings goals are fully funded.This article is for educational and informational purposes only and does not constitute individual financial, legal, or investment advice. Readers should consult a certified financial planner or tax professional regarding their specific financial circumstances.Related: S&P 500 surge triggers critical 401(k) pivot

AEW Redemption 2026 results as Speedball Mike Bailey becomes No. 1 Contender for the AEW International Title in a show-opening ladder match.

Eli Lilly (LLY) stock has turned into one of the best comeback trades of 2026.Shares closed at $1,196.03 on July 24, up nearly 11% year to date after a rough start dragged the stock below $900 in the spring.Lilly shares have climbed about 39% since the company’s first-quarter report, according to Goldman Sachs.Now the bank is telling clients where the next move comes from, and it is not the product most headlines are chasing.What Goldman Sachs expects from Eli Lilly’s second-quarter earningsGoldman Sachs is holding a Buy rating and a 12-month price target of $1,283 on Eli Lilly heading into the Aug. 5 report, Yahoo Finance reported. That target sits about 7% above where the stock closed on July 24.For the second quarter, Goldman expects $20.8 billion in revenue, roughly in line with the $20.5 billion Visible Alpha consensus, and adjusted earnings of $5.83 a share.The bank’s forecast reflects a $2.8 billion acquired research and development charge, which weighs on the reported number.Eli Lilly confirms Aug. 5 as the date for its second-quarter earnings call.Why Foundayo’s soft start may not sink Eli Lilly stockFoundayo is Lilly’s new oral obesity pill, and its debut has been slower than Wall Street hoped.Goldman projects just $40 million in second-quarter Foundayo sales, against a consensus near $100 million.Foundayo (orforglipron) is the only approved once-daily obesity pill with no food or water restrictions, Lilly noted when the drug won FDA approval in April.More Eli Lilly Stock:JPMorgan raises Eli Lilly stock price target to $1,400UBS lifts Eli Lilly stock target to $1,425Ozempic maker takes biggest rival to court over weight-loss drug adsWeekly prescriptions for Foundayo have stalled for five straight weeks after an early peak, Jefferies noted, citing IQVIA data.Goldman cut its 2026 U.S. Foundayo estimate to $755 million from $1.1 billion to reflect the slower sales.The bank still expects Foundayo to be a top question on the Aug. 5 call, yet it argues the stock’s fate rests elsewhere.The number Goldman Sachs says will move Eli Lilly stockGoldman’s note says the size of Lilly’s next guidance raise is the single most important variable for how the stock reacts on report day.Lilly currently guides to $83 billion to $85 billion in 2026 revenue. Goldman sees room for a raise of up to $1 billion and models $86.1 billion for the year.In plain terms, guidance is the company’s own revenue forecast. When Lilly lifts it, investors read that as management confidence backed by real demand.Goldman flags one catch. Its client conversations suggest many investors already expect a raise, so some of that optimism may be priced in.That sets up a familiar earnings-season trap, where a good result still disappoints because expectations ran higher.

Eli Lilly reports second-quarter results on Aug. 5, with its obesity and diabetes franchise in focus.jetcityimage / Getty Images

How OUS Mounjaro became the real engine for LLY stockThe second driver Goldman highlights is Lilly drug Mounjaro, sold outside the United States.The bank forecasts $4.95 billion in second-quarter OUS Mounjaro sales, about 10% above the $4.5 billion consensus.OUS simply means “outside the U.S.,” and this line has carried Lilly’s gains for several quarters running.Mounjaro already holds roughly 60% of the incretin market in countries such as Brazil and Korea, Morgan Stanley noted in May.Related: Lilly quietly hands Chinese partner its cancer drugDomestically sold Mounjaro is steadier, with Goldman modeling $4.4 billion, which is close to consensus. Zepbound is the third leg of Lilly’s obesity lineup, and early signs point to faster volume growth since the July 1 Medicare change.The takeaway for readers is direct. International demand, not the new pill, is what analysts are watching for surprises.Eli Lilly stock versus the market and its rivalLilly’s rebound stands out against both the broader market and its closest competitor.Here is how LLY has traded in 2026:Eli Lilly vs. key benchmarks, 2026Eli Lilly: up about 11% year to date, according to Google FinanceShares up roughly 39% since first-quarter results, according to Goldman SachsRival Novo Nordisk, maker of Ozempic, has struggled, and the two are now in a legal fight over advertising claims.The gap reflects a simple reality. Lilly’s obesity and diabetes franchise keeps winning customers from rivals, CNBC noted.Lilly holds about 60% of the combined U.S. GLP-1 market.What Eli Lilly investors should watch on August 5Several things still need to break Lilly’s way for the bull case to hold.Watch these signals when the company reports:The guidance raise. A lift toward Goldman’s $86.1 billion would confirm demand is outrunning lower U.S. prices.OUS Mounjaro. A beat above $4.5 billion keeps the main profit engine intact.Medicare traction. The Medicare GLP-1 Bridge program began July 1, letting eligible Part D patients pay about $50 a month.Foundayo’s trajectory. Investors want signs the pill’s flat prescription trend is turning.Goldman also points to pipeline risk. The firm noted that retatrutide, a next-generation obesity candidate, saw its filing timeline slip to the first quarter of 2027 from late 2026.The risks that could still hit Eli Lilly stockGoldman lists the main threats: alarger drop in obesity-drug pricing, market-share losses to competitors, and weak clinical data on pipeline drugs.Pricing is the risk to be most cautious about. According to Lilly’s earnings report, U.S. pricesfell 13% in the first quarter even as volume surged.There is also a demand risk further out. A survey this year found some large employers may drop GLP-1 coverage in 2027. That would affect both Zepbound and Foundayo.Anyone weighing LLY should size the position to their own risk tolerance, since stocks priced for perfection fall hard when a quarter disappoints.The bottom line for Eli Lilly stockGoldman Sachs is still bullish on Eli Lilly, holding its Buy rating and $1,283 target, which implies modest gains from current levels. But the bank is steering investors away from the obvious storyline, since a soft Foundayo quarter is already widely expected.The real test on Aug. 5 is whether Lilly raises guidance enough to satisfy a market that already expects good news, and whether international Mounjaro sales keep beating forecasts.If both land, the 2026 comeback has room to run. If the guidance raise isn’t high enough, even a solid quarter could stall the stock.For everyday investors, watch the raise and the overseas numbers, not just the new pill that owns the headlines.Related: Eli Lilly’s hottest drugs face a quiet new threat